Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1674 (Showing 1641 to 1660) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma Ola Landgren NCI, DCEG, GEB PLCO Jun 7, 2006 2005-0017
Functional DNA Repair Assays for Lung Cancer Risk: Prospective Analysis Alice Sigurdson NCI PLCO May 17, 2006 2005-0013
Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer Timothy Church University of Minnesota PLCO Apr 21, 2006 2005-0029
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021
Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort Catherine McCarty Marshfield Clinic Research Foundation PLCO Apr 21, 2006 2005-0027
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0024
Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial Timothy Church University of Minnesota PLCO Mar 31, 2006 2006-0307
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-1 CT Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00324
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-0 CXR Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00391
Iron homeostasis and colorectal adenoma risk in the Prostate, Lung, Colorectal & Ovarian (PLCO) Cancer Screening Trial Amanda Cross NCI, DCEG, NEB PLCO Oct 24, 2005 2005-0012
Cell Cycle Variants and Metastatic Prostate Cancer Risk Adam Kibel Washington University PLCO Sep 23, 2005 2005-0001
Inflammation regulation: Gene variants and inflammatory markers in colorectal neoplasia Sonja Berndt NCI, DCEG, OEEB PLCO Aug 17, 2005 2005-0011
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators Daniel W. Cramer Brigham and Women's Hospital / Harvard Medical School PLCO Aug 17, 2005 2005-0009
Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma Nathaniel Rothman - PLCO Aug 17, 2005 2005-0002
Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort- Nutritional Factors Regina Ziegler NCI, DCEG, EBP PLCO Aug 17, 2005 2005-0010
Telomere length, mitochondrial DNA mass, and risk for major chronic diseases Richard Hayes New York University PLCO Aug 17, 2005 2005-0006
Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer Anna Lokshin University of Pittsburgh PLCO Aug 17, 2005 2005-0008